IPSI Telemed PsOwell in PsA

• Research type

  Research Study

• Full title

  Use of telemedicine to address ‘off target’ symptoms in psoriatic arthritis (PsA): implementation of PsOWellTM in PsA.

• IRAS ID

  318591

• Contact name

  Laura Coates

• Contact email

  laura.coates@ndorms.ox.ac.uk

• Sponsor organisation

  Perelman School of Medicine, University of Pennsylvania

• Clinicaltrials.gov Identifier

  NCT05631223

• Duration of Study in the UK

  1 years, 9 months, 30 days

• Research summary

  We will conduct an interventional study to test the acceptability, feasibility, and effectiveness of structured telemedicine visits to encourage lifestyle changes that will improve quality of life, disease impact, and disease activity in patients with psoriatic arthritis (PsA). The proposed trial will be embedded within clinical care. This is a 2- year interventional trial that will enroll 87 patients with active psoriatic arthritis despite stable therapy among three centers. The intervention employs PsOWellTM, a program that trains clinicians to utilize motivational interviewing to help patients set goals and make lifestyle/behavior changes for holistic management of psoriasis.

• REC name

  Yorkshire & The Humber - Leeds East Research Ethics Committee

• REC reference

  23/YH/0072

• Date of REC Opinion

  26 Apr 2023

• REC opinion

  Further Information Favourable Opinion